Role of Phenol-Soluble Modulins in Formation of Staphylococcus aureus Biofilms in Synovial Fluid. by Dastgheyb, Sana S et al.
Thomas Jefferson University
Jefferson Digital Commons
Department of Orthopaedic Surgery Faculty Papers Department of Orthopaedic Surgery
7-1-2015
Role of Phenol-Soluble Modulins in Formation of
Staphylococcus aureus Biofilms in Synovial Fluid.
Sana S Dastgheyb
Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious
Diseases, National Institutes of Health; Department of Orthopedic Surgery, Thomas Jefferson University
Amer E Villaruz
Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious
Diseases, National Institutes of Health
Katherine Y Le
Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious
Diseases, National Institutes of Health
Vee Y Tan
Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious
Diseases, National Institutes of Health
Anthony C Duong
Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious
Diseases, National Institutes of Health
See next page for additional authors
Let us know how access to this document benefits you
Follow this and additional works at: http://jdc.jefferson.edu/orthofp
Part of the Orthopedics Commons
This Article is brought to you for free and open access by the Jefferson Digital Commons. The Jefferson Digital Commons is a service of Thomas
Jefferson University's Center for Teaching and Learning (CTL). The Commons is a showcase for Jefferson books and journals, peer-reviewed scholarly
publications, unique historical collections from the University archives, and teaching tools. The Jefferson Digital Commons allows researchers and
interested readers anywhere in the world to learn about and keep up to date with Jefferson scholarship. This article has been accepted for inclusion in
Department of Orthopaedic Surgery Faculty Papers by an authorized administrator of the Jefferson Digital Commons. For more information, please
contact: JeffersonDigitalCommons@jefferson.edu.
Recommended Citation
Dastgheyb, Sana S; Villaruz, Amer E; Le, Katherine Y; Tan, Vee Y; Duong, Anthony C; Chatterjee,
Som S; Cheung, Gordon Y C; Joo, Hwang-Soo; Hickok, Noreen J; and Otto, Michael, "Role of
Phenol-Soluble Modulins in Formation of Staphylococcus aureus Biofilms in Synovial Fluid."
(2015). Department of Orthopaedic Surgery Faculty Papers. Paper 77.
http://jdc.jefferson.edu/orthofp/77
Authors
Sana S Dastgheyb, Amer E Villaruz, Katherine Y Le, Vee Y Tan, Anthony C Duong, Som S Chatterjee, Gordon
Y C Cheung, Hwang-Soo Joo, Noreen J Hickok, and Michael Otto
This article is available at Jefferson Digital Commons: http://jdc.jefferson.edu/orthofp/77
Role of Phenol-Soluble Modulins in Formation of Staphylococcus
aureus Biofilms in Synovial Fluid
Sana S. Dastgheyb,a,b Amer E. Villaruz,a Katherine Y. Le,a Vee Y. Tan,a Anthony C. Duong,a Som S. Chatterjee,a*
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Pathogen Molecular Genetics Section, Laboratory of Human Bacterial Pathogenesis, National Institute of Allergy and Infectious Diseases, National Institutes of Health,
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Staphylococcus aureus is a leading cause of prosthetic joint infections, which, as we recently showed, proceed with the involve-
ment of biofilm-like clusters that cause recalcitrance to antibiotic treatment. Here we analyzed why these clusters grow extraor-
dinarily large, reaching macroscopically visible extensions (>1 mm). We found that while specific S. aureus surface proteins are
a prerequisite for agglomeration in synovial fluid, low activity of the Agr regulatory system and subsequent low production of
the phenol-soluble modulin (PSM) surfactant peptides cause agglomerates to grow to exceptional dimensions. Our results indi-
cate that PSMs function by disrupting interactions of biofilmmatrix molecules, such as the polysaccharide intercellular adhesin
(PIA), with the bacterial cell surface. Together, our findings support a two-step model of staphylococcal prosthetic joint infec-
tion: As we previously reported, interaction of S. aureus surface proteins with host matrix proteins such as fibrin initiates ag-
glomeration; our present results show that, thereafter, the bacterial agglomerates grow to extremely large sizes owing to the lack
of PSM expression under the specific conditions present in joints. Our findings provide a mechanistic explanation for the re-
ported extreme resistance of joint infection to antibiotic treatment, lend support to the notions that Agr functionality and PSM
production play a major role in defining different forms of S. aureus infection, and have important implications for antistaphy-
lococcal therapeutic strategies.
Staphylococcus aureus is a major cause of septic arthritis andorthopedic infections, in particular those developing on pros-
thetic joints after arthroplasty (1). In the presence of a prosthetic
device, joint infection rates are at about 1 to 2% (2). Joint infec-
tions can cause prolonged disability and increased health care
costs, due to prolonged antibiotic treatment, multiple surgeries,
and, in difficult cases, joint fusion. If recalcitrant to treatment,
these infections can cause significant morbidity, including loss of
limb, systemic infection, and even death (3).
Antibiotic treatment alone is usually insufficient to eradicate
joint infections. We recently showed that the pronounced recalci-
trance of S. aureus joint infections to antibiotic treatment is due to
exceptionally strong bacterial aggregation and biofilm formation,
which renders even the high concentrations of antibiotics given
prophylactically to patients ineffective (4). Biofilms are surface-
attached bacterial agglomerations that frequently develop on in-
dwelling medical devices (5). The matrix that connects cells in a
biofilm consists of a variety of chemically different macromole-
cules, such as polymeric proteins, teichoic acids, extracellular
DNA (eDNA), and polysaccharides (6). The polysaccharide inter-
cellular adhesin (PIA; also named poly-N-acetylglucosamine
[PNAG]) is the main biofilm exopolysaccharide in staphylococci
(7, 8).
Using a genome-wide screen, our previouswork identified spe-
cific S. aureus factors that are crucial for the establishment of bio-
films and biofilm-like aggregates in synovial fluid (SF) isolated
from traumatized joints (4). These included, first and foremost,
surface-attached proteins that bind to human fibrin and fibronec-
tin, which are human matrix proteins that are present in trauma-
tized and infected joints (1, 9). S. aureus mutants defective in the
fibrinogen-binding protein ClfA or ClfB, or the fibronectin-bind-
ing protein FnbA or FnbB, were unable to produce the macro-
scopic aggregates that the corresponding wild-type strain formed
in SF.
In the present study, we analyzed the mechanistic underpin-
nings of the exceptionally high level of aggregate formation in SF,
by testing whether this extreme phenotype is due to altered ex-
pression of distinct bacterial factors. In addition to evaluating
whether altered expression of the aforementioned surface binding
proteins plays a role, we analyzed whether the accessory gene reg-
ulator (Agr) and the Agr-regulated phenol-soluble modulins
(PSMs) are involved. The accessory gene regulator (Agr) is a quo-
rum-sensing system in charge of regulating virulence traits in
staphylococci depending on the density of the bacterial popula-
tion (10). Notably, it is a master regulator of biofilm formation
(11, 12). In vitro, agr deletion mutants of S. aureus and S. epider-
midis grow thicker and less structured biofilms than the isogenic
wild-type strains (13–15).
PSMs are main molecular effectors of the impact that Agr has
on biofilm development (13, 15). They are under strict and direct
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control of Agr by direct binding of the AgrA response regulator to
the psm operon promoters (16). There are three loci in S. aureus
that encode PSMs: the psm locus encodes the peptides PSM1
through PSM4; the psm locus encodes PSM1 and PSM2;
and RNAIII includes the gene encoding the PSM -toxin (17, 18).
In vitro studies using TSB growth medium showed that all S. au-
reus PSMs impact biofilm formation in a similar way (13), i.e.,
they structure biofilms and lead to biofilm dispersal, which is
likely due to their surfactant properties. While PSMs are impor-
tant for biofilm structuring and thus biofilm development, the
overall impact of PSMs on the extent of biofilm formation is neg-
ative because PSMs disperse biofilms (13, 15). Thus, these factors
could not be identified in our recent work, which sought to iden-
tify factors with a generally positive impact on biofilm-like aggre-
gation (4). Notably, the role of PSMs during S. aureus in vivo
biofilm infection is notwell understood.While the PSM-mediated
dispersal effect has been shown to promote systemic dissemina-
tion of biofilm-associated infection, it is not known if lack of PSM
production also leads to more extensive in vivo biofilm formation
on indwelling devices (13).
In the present study, we show that low activity of Agr and low
PSM production in SF are a major cause for the exceptionally
strong aggregation behavior of S. aureus in SF. We demonstrate
that PSM production has a key role in defining biofilm extension
under conditions that exemplify an in vivo situation and provide
evidence that contributes to our understanding of how PSMs af-
fect biofilm dispersal.
MATERIALS AND METHODS
Ethics statement.Human SFwas drained from the joint during total knee
arthroplasty in the operating room and collected with permission of the
Thomas Jefferson University Institutional Review Board (IRB). A waiver
for the requirement of informed written consent was obtained, because
the samples were deidentified, obtained during routine procedures, and
would normally have been discarded. Human serum was obtained from
the blood bank of the NIH with an existing IRB protocol.
Preparation and storage of SF. SF that was obtained as mentioned
above was stored at 4°C for a period not exceeding 6 months before use.
Cellularity was not recorded. All samples containing blood upon visual
examination were discarded. Of note, due to the conditions of storage,
white blood cells were inactive (dead) at the time of use of SF for our
experiments.
Strains and growth conditions. All experiments were performed us-
ing strain S. aureus LAC (pulsed-field type USA300), a community-asso-
ciatedmethicillin-resistant strain, or its derivatives. TheUSA300 lineage is
the main source of skin and prosthetic-joint infections (PJIs) in the
United States (19, 20). The total psmmutant (with the psm and psm
operons deleted and translation of -toxin abolished by mutation of the
hld gene start codon) and the agr mutant of LAC were produced by
sequential allelic replacement and by phage transduction from strain
RN6911, respectively, andwere previously described (18, 21). Of note, the
LAC wild-type strain and its agr and psmmutants do not show signif-
icant differences in growth rates and yield in SF when grown at 37°C in
shaking incubators (data not shown). Strain LAC was transformed by
electroporation with plasmids based on the pTX plasmid background,
constitutively expressing the psm (15), psm (this study), hld (22), or
agrA (16) gene/operon under the control of the xyl promoter. The xyl
repressor gene has been removed in that plasmid series to produce a con-
stitutive mode of expression (18). The control strain harbors the corre-
sponding pTX16 plasmid (18). Strains were grown in SF, serum, or tryp-
tic soy broth (TSB), as indicated. Oligonucleotides used are shown in
Table 1, and strains used are shown in Table 2.
Macroscopic determination of bacterial aggregation.Aggregate for-
mation was monitored by UV-fluorescent imaging of ethidium bromide
(EtBr)-labeled bacteria (10 g/ml EtBr, 10 min in the dark).
Measurement of aggregate size distribution.Aggregate size distribu-
tion was measured using a T3 Cellometer (Nexcelom) as described previ-
ously (4). Briefly, overnight cultures were centrifuged and resuspended to
a concentration of 1010 CFU/ml in sterile phosphate-buffered saline
(PBS). Onemilliliter of SF, TSB, or serumwas prewarmed to 37°C, 5l of
the bacterial suspension and 20 l of trypan blue were added, and the
sample was incubated for 20 min at 37°C with agitation. The Cellometer
can detect aggregates between 3 and 100m in size. The parameters were
set to detect oddly shaped aggregates (roundness was not set as a deter-
mining factor).
qRT-PCR. Strain LAC (initial inoculum 104 CFU/ml) was grown for 8
h in TSB, SF, or serum, in a shaking incubator at 180 rpm and 37°C.
mRNAwas collected using the RNeasyminikit (Qiagen), and quantitative
real-time PCR (qRT-PCR) was performed as described previously (23).
Oligonucleotides used are described in Table 1. All probes were labeled
with 5=-carboxyfluorescein. All experiments were performed in triplicate,
and data were normalized against the housekeeping gyrB gene.
Creation of luciferase reporter gene fusion constructs and lumines-
cence measurement. The lux operon (luxABCDE; 5.7 kb) was amplified
from plasmid pXen5 (kindly given by K. Francis) (24) using the primers
luxBamHI and luxSalI and cloned into plasmid pLL29 (a gift fromC. Lee)
(25). The P2, P3, psm, and psm promoters were amplified from LAC
genomic DNA and cloned into the resulting plasmid, pLL29lux, using
SacI/BamHI (psm promoter) or EcoRI/BamHI (all other promoters)
restriction sites. Then, the integration procedure protocol was performed
as described previously (25). Briefly, the pLL29lux reporter fusion plas-
mids were electroporated into strain RN4220 carrying plasmid pLL2787,
which contains the 11 int gene. After selecting for clones in which the
integration of the respective pLL29 plasmid into the host attB sites had
occurred, the chromosome-integrated pLL29 plasmids carrying the re-
spective lux reporter fusion were phage transduced into strain LAC. Cor-
rect integration was verified by analytical PCR. Light emitted by the lucif-
erase gene reporter fusion constructs was measured using a Victor
(Perkin-Elmer) instrument.
Immunoblotting test for PIA. Strain LAC was inoculated at 104 CFU
from a preculture grown in TSB and grown for 24 h at 37°C and 180 rpm
in 1 ml of either TSB, serum, or SF. Immunodetection of polysaccharide
intercellular adhesin (PIA) was then performed as described by Cramton
et al. (26) to minimize cross-reactivity to protein A. In brief, all cultures
were resuspended in 1 ml TSB to an optical density at 600 nm (OD600) of
10.0. Each sample was centrifuged and resuspended in 0.5 M EDTA (pH
8.0) and incubated for 5min at 100°C. Sampleswere centrifuged and 40l
of supernatant were incubated with 10 l proteinase K (20 mg/ml) for 30
min at 37°C. A 3.5-l portion of each sample was spotted onto nitrocel-
lulose, dried, and blocked with 3% bovine serum albumin (BSA) for 1 h
prior to the addition of anti-PIA serum (1:1,000; from rabbit). The mem-
brane was then incubated at 4°C for 18 h. Afterwards, it was washed five
times with Tris-buffered saline (TBS)–Tween (0.1%) and incubated for 2
h with Cy5-labeled goat anti-rabbit IgG (Life Technologies), followed by
washing five times with TBS-Tween (0.1%). Signals were detected using a
Typhoon Trio variable-mode imager (GE Healthcare).
SEM. To prepare for scanning electron microscopy (SEM), samples
were fixed with 2% paraformaldehyde in 0.1M sodium phosphate buffer.
Samples were then sent to the SEM facility at Rocky Mountain Laborato-
ries, NIAID, where they were sputter coated using a South Bay Technol-
ogy IBS/e instrument and imaged on a Hitachi SU8000 electron micro-
scope.
Biofilmassays.For biofilmanalysis by confocal laser scanningmicros-
copy (CLSM), strains were incubated in TSB under static conditions in an
8-well borosilicate plate for 8 h. TSBwas aspirated, replacedwith 200l of
SF, and incubated for a further 24 h. Samples were then washed gently
three times with sterile PBS, stained with 4 M propidium iodide for 30
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min at 37°C, and imaged using a Zeiss LSM700 confocal microscope.
Total biovolume was calculated using Imaris software from three ran-
domly chosen fields. This protocol was used for all biofilmCLSM analyses
with the exception of the protocol used for the image shown in Fig. 1B, for
which S. aureus (109 CFU/ml) was incubated in SF for 20 min, stained
with 4 M propidium iodide, and immediately imaged.
Measurement of PSMs. After butanol extraction of PSMs, PSM pro-
duction was analyzed by reversed-phase high-pressure liquid chromatog-
raphy/electrospray mass spectrometry as described previously (27).
Statistics. Statistical evaluationwas performed usingGraphPad Prism
version 6.02, with t tests for the comparison of two and one-way ANOVA
for the comparison of more than two groups. Multiple comparisons with
one-way ANOVA were performed using Tukey’s posttests.
RESULTS
Biofilms and free-floating aggregates form in synovial fluid iso-
lated from patients. In the present study, we used an ex vivo ap-
TABLE 1 Oligonucleotides used in this study
Use and primer Sequence
qRT-PCR
RNAIII-for GTGATGGAAAATAGTTGATGAGTTGTTT
RNAIII-rev GAATTTGTTCACTGTGTCGATAATCC
RNAIII probe TGCACAAGATATCATTTCAACAATCAGTGACTTAGTAAAA
psm-for TATCAAAAGCTTAATCGAACAATTC
psm-rev CCCCTTCAAATAAGATGTTCATATC
psm probe AAAGACCTCCTTTGTTTGTTATGAAATCTTATTTACCAG
agrA-for CGTAAGCATGACCCAGTTGGT
agrA-rev CCATCGCTGCAACTTTGTAGAC
agrA probe ATTATTTTCGTTACGAGTCACAGTGAACT
icaA-for TGAACCGCTTGCCATGTG
icaA-rev CACGCGTTGCTTCCAAAGA
icaA probe TGGATGTTGGTTCCAGAAACATTGGGAG
clfA-for AGGTTCTGGTGACGGTATCGA
clfA-rev TCAATTTCACCAGGCTCATCAG
clfA probe AAACCAGTTGTTCCTGAAC
clfB-for TTCCAATGCGCAAGGAACTAG
clfB-rev CAGCATTTACTACAGGTTCAGCAACT
clfB probe AGACTACGTACAGCTCTCGTTCTAACACTT
fnbA-for TGAGCCAGAAACTCCAACAC
fnbA-rev TGGCAGGTGGTACTGGTTTA
fnbA probe CGCCAACACCAGAGGTACCAGC
fnbB-for AGGAATTAAGGCGGGAGATT
fnbB-rev TGTCGCCATAACTTGACCAT
fnbB probe CTCAACACTGCGTAAAGTTCCGGAGA
rsbU-for ACCATAACGATGGCACAATG
rsbU -rev TCCATAAGAATCCATGCCAA
rsbU probe TCCCAATGACATCTGCAACAGCA
TRAP-for CGTTTGTTAAGACCTGCTAAAGG
TRAP-rev TGTCCGCTTGAACCAAAGTA
TRAP probe TGCATGTCGATCAGCAAATCCG
Luciferase reporter gene fusion construction and verification
luxBamHI ATGCGGATCCTGCAGATGAAGCAAGAGGAG
luxSalI ATGCGTCGACGCAGCGGTATTTTTCGATCA
P2prEco ATGCGAATTCCTCATCAACTATTTTCCATCACATCTCTGT
P2prBam CAATTTTACACCACTCTCCTCACTGGGATCCCATTATACG
P3prBam ATGCGGATCCCTCATCAACTATTTTCCATCACATCTCTGT
P3prEco CAATTTTACACCACTCTCCTCACTGGAATTCCATTATACG
psmprSacI GGCTTAGAAGGCCATTGCTGAGCTCAGCTGAGCTACCAGG
psmprBam TATCTTTAATTGCGTTAAATAAACCTTCCATTGAAAACAGGATCCAAAA
psmprEco GCCTAGACGAGACCTAACGTGGAATTCGTTTTAAAC
psmprBam GATGCCAGCGATGATACCCATTAAGATTGGATCCTTGCTTAT
scv4 ACCCAGTTTGTAATTCCAGGAG
scv8 GCACATAATTGCTCACAGCCA
scv9 GCTGATCTAACAATCCAATCCA
scv10 TATACCTCGATGATGTGCATAC
Cloning of psm operon
Psm1Bam CTTCAAATGGATCCTTTAAGGAGTGTTTTCAATGGAAGG
Psm2Mlu CTGAGTGCATAACATACGCGTATGCTCACCCAGTTTATTTTAAAG
Dastgheyb et al.
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proach to study the mechanistic underpinnings of the formation
of free-floating and surface-attached S. aureus agglomerates (bio-
films) during prosthetic joint infection (PJI).We isolated synovial
fluid (SF) from noninfected patients undergoing surgery, thus re-
producing the environmental conditions the bacteria encounter
when mounting a postoperative joint infection. All experiments
were performed using strain LAC, representing pulsed-field type
USA300, the predominant cause of PJI in the United States (19).
Even when SF was isolated from patients who had received
high doses of prophylactic antibiotic, which leads to high concen-
trations of antibiotic in SF (28), biofilms formed on titaniumdisks
over the course of 48 h (Fig. 1A), underscoring the notion that S.
aureus PJIs are recalcitrant to antibiotic treatment due to the for-
mation of biofilms (4, 28). Notably, extensive biofilm-like aggre-
gates formed withinminutes after incubation of the bacteria in SF
andwere characterized by the attachment of fibrousmaterial (Fig.
1B and C).
Extreme agglomeration of S. aureus in SF is not due to in-
creased expression of proteins interacting with host matrix
molecules.Wefirst analyzed expression of the factors determined
in our previous transposon bank screen to be essential for aggre-
gation in SF (4) and asked if increased expression of these factors
causes the exceptional degree of agglomeration. These factors in-
cluded mostly surface binding proteins, namely, the fibrinogen-
binding proteins ClfA and ClfB and the fibronectin-binding pro-
teins FnbA and FnbB (4). We have shown that the fibrinolytic
protease plasmin can degrade the agglomerates, indicating that
fibrin plays a major role among the host-derived factors that con-
tribute to agglomerate formation (4). Furthermore, fibrin binding
is considered more significant than binding to fibronectin, since
fibrin concentration is higher in traumatized joints (9). The fi-
bronectin-binding proteins showed increased expression in SF
over serum and TSB (FnbA, 3.9 times higher than in TSB and 3.2
times higher than in serum; FnbB, 12.1 times higher than in TSB
and 7.6 times higher than in serum) (Fig. 2). However, expression
of the fibrinogen-binding proteins in SF was low in comparison,
in particular in the case of ClfA (0.12 times higher than in TSB
and 0.17 times higher than in serum) (Fig. 2). Furthermore,
absolute expression values were by far highest for ClfA among
the four surface binding proteins (highest mean Qgene/QgyrB
values [where Qgene is the abundance of a given transcript and
QgyrB is the abundance of the gyrB transcript] achieved: ClfA,
8.3; ClfB, 1.5; FnbA, 0.5; FnbB, 0.6), which is why the pro-
nounced differences observed for this fibrinogen-binding pro-
tein matter most in relative terms (Fig. 2). Thus, while fibrin-
ogen- and fibronectin-binding proteins are required as a basis
of aggregate formation in SF, our results indicate that, taken
together, differences in their expression do not appear to con-
tribute considerably to the strong degree of aggregation behav-
ior in SF.
Expression levels of the regulatory factors RsbU andTRAP also
previously identified in our screen (4) were roughly equivalent in
SF and serum, with a small increase over expression in TSB, indi-
cating that these are also unlikely to be responsible for the strong
aggregation phenotype (Fig. 2).
S. aureus shows low activity of Agr and low production of
PSMs in SF. As an alternative explanation, we evaluated whether
low activity of the biofilm regulator Agr is responsible for the
excessive formation of aggregates and biofilms in SF. To investi-
gate this hypothesis, we constructed reporter gene fusion con-
structs. In these constructs, the agr P3 or P2 promoters were fused
to the lux genes driving production of light-emitting luciferase. P3
drives expression of RNAIII, the intracellular regulator of most
Agr targets (29), and P2 drives expression of the Agr proteins
making up the Agr autoregulatory quorum-sensing circuit (30).
Notably, all luciferase promoter fusions were cloned in the ge-
nome of strain LAC. In contrast to plasmid-based systems, which
are often used for this purpose, genome insertion ensures that the
obtained results accurately reflect natural expression and are not
due to multiple, plasmid-introduced copies of the respective
genes. During all stages of in vitro growth, Agr (P2 and P3) activity
in human SF was extremely low, lower than in human serum and
much lower than in TSB (Fig. 3A and B). This was verified using
qRT-PCR with the agrA (controlled by the P2 promoter) and
RNAIII (controlled by the P3 promoter) genes (Fig. 3C and D).
To analyze expression of the Agr-controlled PSMs in SF, we
again used genome-integrated luciferase reporter gene constructs
in strain LAC in addition to qRT-PCRmeasurements. The results
confirmed our expectations, inasmuch as expression of the psm
and psm loci was extremely low (Fig. 3E to G), as shown above
for RNAIII (Fig. 3C), which also contains the hld gene encoding
the -toxin. Furthermore, we measured PSM production on the
TABLE 2 Strains and plasmids used in this study
Strain or plasmid Description Reference
Strains
LAC USA300, ST8, clinical CA-MRSA clone
LAC agr agrmutant of strain LAC, obtained by phage transduction from strain RN6911 18
LAC psm Total psm deletion mutant; psm and psm operons are deleted; translation of hld is abolished by start codon mutation 21
LAC P2-lux Strain LAC containing genome-integrated luxABCDE genes under the control of the S. aureus Agr P2 promoter This study
LAC P3-lux Strain LAC containing genome-integrated luxABCDE genes under the control of the S. aureus Agr P3 promoter This study
LAC psm-lux Strain LAC containing genome-integrated luxABCDE genes under the control of the S. aureus psm promoter This study
LAC psm-lux Strain LAC containing genome-integrated luxABCDE genes under the control of the S. aureus psm promoter This study
Plasmids
pTX16 Control plasmid 18
pTXpsm Tet
r, psm operon under constitutive control of the xylose promoter 18
pTXpsm Tet
r, psm operon under constitutive control of the xylose promoter This study
pTXhld Tet
r, hld gene under constitutive control of the xylose promoter 22
pTXagrA Tet
r, agrA gene under constitutive control of the xylose promoter 16
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protein level (Fig. 3H), which confirmed the results achieved
on the transcriptional level. These results demonstrate ex-
tremely low production of all PSMs in SF and suggest that low
PSM production is a major reason for the marked formation of
aggregates in SF.
Low production of the Agr-controlled phenol-soluble
modulins is amajor factor promoting bacterial aggregation and
formation of biofilms in SF.To analyze whether the observed low
activity of Agr in SF and low production of the biofilm-dispersing
PSMs are responsible for the aggregative phenotype in SF, we de-
termined the extent of bacterial agglomeration of wild-type and
isogenic agr and psm mutants as visualized microscopically
and using a Cellometer. In the psm mutant, all psm genes have
been removed or translation has been abolished (21). We found
that all strains, notably including the wild-type strain, showed
extensive agglomeration in SF, while in TSB, only agr and psm
mutants produced agglomerates (Fig. 4). Furthermore, the extent
of agglomeration in SF was not statistically different in the wild
type and the agr and psm mutants. These results showed that
low activity of Agr and suppression of the Agr-controlled PSMs
cause exceptionally strong aggregate production in SF.
To provide further evidence for the role of PSMs and Agr in
aggregation in SF and delineate the specific role of different PSM
FIG 1 Synovial fluid promotes multicellular aggregation of Staphylococcus
aureus. (A) Biofilm formation of S. aureus strain LAC (USA300) on a titanium
disk incubated for 48 h in SF from a patient who had received 2 g of cefazolin.
(B and C) Formation of free-floating aggregates of strain LAC inoculated from
a preculture in TSB and incubated for 20 min in SF. Aggregates were imaged
using CLSM (B) and SEM (A and C). Extracellular host-derived fibrous ma-
terial is pseudocolored pink; S. aureus cells are yellow. (B) CLSM was per-
formed with staining with propidium iodide, staining cells and matrix red.
FIG 2 Expression of genes previously identified to be required for aggregation
in SF (clfA, clfB, fnbA, fnbB, trap, and rsbU) in SF, TSB, and serum. The six
genes previously identified by a transposon bank screen to be required for the
aggregation behavior in SF were assayed by qRT-PCR for comparative expres-
sion in SF versus human serum and TSB. Samples were taken at 8 h of sus-
pended growth. The experiments were performed in triplicate. Error bars
show standard deviations (SD). *, P	 0.05; **, P	 0.01; ***, P	 0.001; ****,
P	 0.0001.
Dastgheyb et al.
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types, we transformed the LAC wild-type strain with plasmids
carrying the psm, psm, hld (encoding -toxin), or agrA genes/
operons under the control of a constitutively active promoter. In
these constructs, low expression of those genes in SF is thus over-
come by constitutive expression. We first analyzed the formation
of macroscopic clusters during 24-h growth in microtiter plates.
In SF, the LAC wild-type strain formed a large cluster, in accor-
dance with our previous results (4); this was not the case in serum
or TSB (Fig. 5). Importantly, no cluster formation was visible
when the strains expressing psm, psm, or hld genes/operons
were incubated in SF. Similarly, no cluster formationwas detected
when agrA, which controls expression of all of these genes, was
expressed (16). Furthermore, the psm mutant, devoid of PSM
production, showed large cluster formation in SF, similar to that
observed with the wild-type and agr strain.
We next analyzed biofilm formation of the constitutive-ex-
pression constructs by confocal laser scanning microscopy
(CLSM) with an analysis of total biovolume. Similar to the results
obtained formacroscopic cluster formation, biofilm formation by
the constructs expressing psm, psm, hld, or agrA was signifi-
cantly less pronounced than that by the wild-type strain (Fig. 6).
Together, these results identify the lack of PSM production as the
main cause for the extensive biofilm and aggregate formation in
SF and show that all PSM types have the capacity to disrupt aggre-
gates.
PSMs work by dispersing biofilm matrix molecules such as
PIA. The surfactant characteristics of PSMs suggest that these
molecules function during biofilm development by disrupting the
interaction of biofilm matrix molecules with each other and the
bacterial cell surface (31). However, this has not yet been exam-
ined experimentally. PIA is considered a major biofilm matrix
FIG 3 Agr activity and PSM production are low in synovial fluid. (A and B)
Activity of the Agr P3 (A) and the Agr P2 promoter (B) measured during
suspended growth in SF, human serum, or TSB, using genome-integrated,
single-copy luxABCDE luciferase operon reporter fusion constructs. (C andD)
Expression of RNAIII (C) and agrA (D) at 8 h of growth, measured by qRT-
PCR. (E and F) Expression of psm (E) and psm (F) promoters during
growth in SF, human serum, or TSB, using genome-integrated, single-copy
luxABCDE luciferase operon reporter fusion constructs. (G) Expression of
psm operon by qRT-PCR, at 8 h of growth. (H) PSM production determined
in culture filtrates after 8 h of growth. All experiments were performed in
triplicate. Error bars show standard deviations (SD). *, P	 0.05; **, P	 0.01;
***, P	 0.001; ****, P	 0.0001.
FIG 4 Aggregate size distribution after incubation of S. aureus under dif-
ferent conditions. (A) Size distribution of aggregates, measured by a Cellom-
eter, after 20 min incubation in the respective fluids (SF or TSB) of LAC
wild-type (WT), isogenicagr deletion, or totalpsm deletion strains. Aggre-
gates between 10 and 100 m were determined; larger aggregates cannot be
measured by this method. (B) Corresponding representative microscopic pic-
tures. Note the absence of clusters in the TSB wild-type sample in both panels.
Scale bars, 50 m.
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component in staphylococci (6). We showed previously that
strain LAC produces a large amount of surface-located PIA when
grown in SF (4). Transcription of the ica PIA biosynthesis operon
(as determined by qRT-PCRof the icaA gene)was not increased in
SF (Fig. 7A). However, immunological assessment using PIA-spe-
cific antibodies revealed that (i) PIA retention on the bacterial
surface was significantly higher in SF than TSB and serum (Fig.
7B) and (ii) PIA was released from the bacterial surface in a PSM-
dependent manner (Fig. 7C). The latter was demonstrated by the
fact that surface PIA levels were similarly high in the isogenic
psm mutant when it was grown in either TSB or SF and in the
wild-type strain grown in SF (conditions without or with very low
PSM production) but significantly higher than PIA surface levels
in the wild-type strain grown in TSB (under which condition
PSMs are produced) (Fig. 7C). These results suggest that PIAma-
trixmolecules are abundant on the bacterial surface in the absence
of PSMs, indicating that PSMs cause separation of the PIAmatrix
molecules from the bacterial surface.
To provide further evidence supporting that mechanism, we
compared cluster formation of the wild-type and psm mutant
strains using scanning electronmicroscopy (SEM). This was done
in TSB, because (i) there is no host-derived fibrous material over-
shadowing bacterial exopolymers during growth in TSB and (ii)
we have shown here that there is virtually no PSM production in
SF. SEM showed only single cells and no cluster formation of the
wild-type strain (in accordance with the results shown in Fig. 4).
In contrast, the psmmutant formed clusters, which had fibrous
material on their surface (Fig. 7D), which—in the absence of host
material such as fibrin—are strongly indicative of the deposition
of bacterial biofilm matrix molecules, such as PIA, but also likely
includes other biofilmmatrix components, such as teichoic acids,
extracellular DNA, and biofilmmatrix proteins. Thus, these find-
ings further confirmed that PSMs interfere with the deposition of
matrix molecules on the bacterial surface.
DISCUSSION
In our previous study, we discovered that S. aureus proteins that
connect the bacteria to the human matrix proteins fibrin and fi-
bronectin are prerequisites for the formation of biofilms and bio-
film-like aggregates during joint infections (4). In the present
study, we asked which factors are responsible for the excessively
strong degree of aggregate and biofilm formation in SF, which is
the basis for the notorious recalcitrance of such infections to an-
tibiotic treatment (28). We identified the low activity of Agr and
consequentially low production of PSMs asmajor factors contrib-
uting to that phenotype. Our results support a two-step model of
aggregate formation during joint infection which includes (i) bac-
terial attachment to fibrin and fibronectin via ClfA, ClfB, FnbA,
and FnbB and (ii) extensive agglomeration of cells and bacterial
matrixmolecules, owing to the absence of the surfactant-like, sep-
arating effect of the Agr-controlled PSMs. It appears surprising at
first glance that there is low activity of the quorum-sensing regu-
lator Agr in cellular aggregates, despite such aggregates represent-
ing a high-cell-density situation. However, we and others have
observed overall low activity of Agr activity in in vitro staphylo-
coccal biofilms (11, 12, 32). Furthermore, there has been consid-
erable doubt about a direct correlation of cell density and the
activity of quorum-sensing systems (33).Whether the low activity
of Agr in SF is due to specific factors that are present in SF, such as
hyaluronic acid (34, 35), or the overall chemical composition of
SF (35) awaits further investigation. One specific possibility that
remains to be explored is whether the increased concentration of
serum proteins in traumatized SF (36) contributes to a quorum-
quenching effect due to sequestration of the Agr pheromone, as
described for apolipoprotein B (37).
FIG 6 PSM expression abolishes biofilm formation in SF. (A) Derivatives of
the LAC wild-type strain containing plasmids (pTX) for constitutive expres-
sion of agrA, psm, psm, or hld genes or a control plasmid (pTX16) were
assayed for biofilm formation in SF under static conditions (24-h growth).
Plasmid-containing strains received 12.5g/ml tetracycline for plasmidmain-
tenance. Biofilms were stained with propidium iodide for CLSM. (B) The total
biovolume was calculated using Imaris software using 3 randomly chosen
image fields. Error bars show standard deviations (SD). ****, P	 0.0001.
FIG 5 PSM expression abolishes the formation of macroscopic cell clusters in
SF. The LAC wild-type strain (WT) was inoculated into 200 l SF, human
serum, or TSB at 104 CFU and incubated under static conditions for 18 h. In
addition, the LACagr andpsm strains and derivatives of the LACwild-type
strain containing either plasmids (pTX) for constitutive expression of agrA,
psm, psm, or hld genes or a control plasmid (pTX16) were inoculated and
grown under the same conditions in SF. Plasmid-containing strains received
12.5 g/ml tetracycline for plasmid maintenance. Afterwards, cell clusters
were visualized by staining with ethidium bromide. Note that large clusters
formed only in the WT (when grown in SF) and SF-grown agr, psm, and
plasmid control samples (arrows), whereas expression of any of the psm loci or
the PSM regulator agrA resulted in abolishment of cluster formation.
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The significance of our results extends beyond joint infection.
For the first time, we provide evidence in a system closely resem-
bling in vivo conditions, and this evidence underscores a key role
of PSM production in defining the extent of S. aureus biofilms.
Specifically, we demonstrate that low PSM production causes
strongly increased biofilm formation. Furthermore, we show that
absence of PSMs leads to increased formation of floating aggre-
gates, which was shown previously only for surface-attached bio-
films (13, 15). Moreover, our results provide previously unavail-
able evidence for the mechanism by which PSMs disperse
biofilms, inasmuch as we demonstrate PSM-dependent release of
PIA from the bacterial surface.
Our results are of particular interest given that in vitro studies
have led to two different models of how PSM production impacts
S. aureus biofilm development. Our previous studies, performed
using TSB, indicated that absence of PSMs leads tomore extensive
and compact biofilm formation, owing to a lack of PSM-mediated
biofilm structuring and dispersal (13). In contrast, using a differ-
ent growth medium, Schwartz et al. observed that PSMs form
amyloid-like fibrils that promote (rather than decrease) biofilm
formation in vitro (38). In our present study, we demonstrate that
under conditions emulating the in vivo situation present during a
biofilm-associated infection, absence of PSMs leads to extensive
formation of biofilms, while the amyloid model of Schwartz et al.
would have predicted that in the absence of PSMs, biofilms would
be less pronounced. In accordance with our previous in vivo re-
sults (13), our present findings further suggest that the role of PSM
amyloid fibrils in biofilm development applies only to a very spe-
cific in vitro setup.
Our results further support the notion that differences in Agr
activity are associated with different types of staphylococcal infec-
tion and demonstrate the crucial role that PSMs play in that asso-
ciation. Mutants that are dysfunctional in Agr have been found
more frequently in chronic, biofilm-associated infections (14, 39)
and in cases of S. aureus bacteremia (40). In contrast, a functional
Agr system and high production of Agr-regulated toxins, such as
PSMs and alpha-toxin, are associatedwith acute forms of S. aureus
infection, such as acute skin and lung infections (18, 41, 42), and
osteomyelitis (43). Since there is continual developing of drugs
targeting the Agr system (44), we caution that the use of Agr-
blocking therapeutics should be limited to certain infection types
and would be counterproductive in others.
In conclusion, the findings from our study indicate that the
exceptional recalcitrance of staphylococcal PJI to antibiotic treat-
ment (28) is due to the specific environment in joints that sup-
presses Agr and production of biofilm-dispersing PSMs, which
together with the interaction with host-derived fibrin leads to the
formation of extensive bacterial agglomerates. These results fur-
ther our understanding about the role Agr and PSMs play in de-
fining biofilm-associated S. aureus disease, which could lead to the
development of antibiofilm therapeutic strategies against PJI. Our
findings suggest that therapeutic strategies against staphylococcal
FIG 7 Growth in SF leads to increased retention of the biofilm exopolysaccharide PIA on cells. (A) Expression of PIA biosynthetic operon (measured by
qRT-PCR of the icaA gene) at 8 h of growth under different conditions. (B and C) Cell-bound PIA after 12 h of growth, measured using detection by anti-PIA
antiserum in immune dot blots followed by densitometry. Error bars show standard deviations (SD). *, P	 0.05; ****, P	 0.0001 (1-way ANOVA versus the SF
value [B] and versus theWT SF value [C]). (D)Wild-type LAC (WT) and the PSM-free isogenicpsm strain were grown for 8 h in TSB, and bacterial cells were
assayed by SEM. Cell clusters were not found in the wild-type strain but were found in high numbers in the psm strain (also compare the results shown in Fig.
3, obtained using a Cellometer).
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PJI should target the host-derived and bacterial factors that con-
tribute to agglomerate formation, such as fibrin and bacterial bio-
film matrix molecules, including PIA.
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